Regarding glioblastoma, some tissue biomarkers have shown to harbour level B3 prognostic (GFAP or estrogen receptor alpha25) or diagnostic value (for example, high expression of Wnt 11, Tenascin precursor or Enolase 126 indicating high WHO grade). This evidence concerns the gene GFAP and glioblastoma.